Logo image of CRE.CA

CRITICAL ELEMENTS LITHIUM CO (CRE.CA) Stock Fundamental Analysis

TSX-V:CRE - TSX Venture Exchange - CA22675W1077 - Common Stock - Currency: CAD

0.45  0 (0%)

Fundamental Rating

3

Overall CRE gets a fundamental rating of 3 out of 10. We evaluated CRE against 797 industry peers in the Metals & Mining industry. While CRE seems to be doing ok healthwise, there are quite some concerns on its profitability. CRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CRE had negative earnings in the past year.
In the past year CRE has reported a negative cash flow from operations.
CRE had negative earnings in each of the past 5 years.
CRE had a negative operating cash flow in each of the past 5 years.
CRE.CA Yearly Net Income VS EBIT VS OCF VS FCFCRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

With an excellent Return On Assets value of -1.44%, CRE belongs to the best of the industry, outperforming 81.30% of the companies in the same industry.
With an excellent Return On Equity value of -1.56%, CRE belongs to the best of the industry, outperforming 82.06% of the companies in the same industry.
Industry RankSector Rank
ROA -1.44%
ROE -1.56%
ROIC N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
CRE.CA Yearly ROA, ROE, ROICCRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

CRE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRE.CA Yearly Profit, Operating, Gross MarginsCRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

CRE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CRE has been increased compared to 5 years ago.
The debt/assets ratio for CRE has been reduced compared to a year ago.
CRE.CA Yearly Shares OutstandingCRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRE.CA Yearly Total Debt VS Total AssetsCRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 8.05 indicates that CRE is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRE (8.05) is better than 70.14% of its industry peers.
CRE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CRE has a Debt to Equity ratio (0.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.05
ROIC/WACCN/A
WACCN/A
CRE.CA Yearly LT Debt VS Equity VS FCFCRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CRE has a Current Ratio of 13.58. This indicates that CRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 13.58, CRE belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
CRE has a Quick Ratio of 13.58. This indicates that CRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 13.58, CRE belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.58
Quick Ratio 13.58
CRE.CA Yearly Current Assets VS Current LiabilitesCRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

CRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -154.29%.
EPS 1Y (TTM)-154.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-204.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 88.11% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-22%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRE.CA Yearly Revenue VS EstimatesCRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 100M 200M 300M 400M 500M
CRE.CA Yearly EPS VS EstimatesCRE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRE. In the last year negative earnings were reported.
Also next year CRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRE.CA Price Earnings VS Forward Price EarningsCRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRE.CA Per share dataCRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

CRE's earnings are expected to grow with 236.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.48%
EPS Next 3Y236.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRITICAL ELEMENTS LITHIUM CO

TSX-V:CRE (8/1/2025, 7:00:00 PM)

0.45

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-18 2025-07-18
Earnings (Next)11-05 2025-11-05/amc
Inst Owners3.23%
Inst Owner ChangeN/A
Ins Owners4.28%
Ins Owner ChangeN/A
Market Cap98.03M
Analysts83.08
Price Target1.49 (231.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.44%
ROE -1.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -7996.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.58
Quick Ratio 13.58
Altman-Z 8.05
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12312.4%
Cap/Depr(5y)9260.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-154.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-204.26%
EPS Next Y-22%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-322.62%
EBIT Next 3Y132.14%
EBIT Next 5Y123.6%
FCF growth 1Y28.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.14%
OCF growth 3YN/A
OCF growth 5YN/A